See the DrugPatentWatch profile for Vuity
Vuity, a prescription eye drop used to treat age-related blurry near vision (presbyopia), generated $163 million in net sales during 2023 [1]. This marks a significant increase from its 2022 net sales of $49 million, reflecting its first full year on the market [1].
How is Vuity performing commercially?
Vuity's sales have seen substantial growth since its U.S. Food and Drug Administration (FDA) approval in December 2021 [2]. The drug achieved $163 million in net sales in 2023, a notable jump from the $49 million reported in 2022 [1]. This upward trend suggests increasing adoption and market penetration for the medication.
What is Vuity and how does it work?
Vuity is the first and only FDA-approved prescription eye drop designed to treat presbyopia, a common condition that makes it difficult to focus on close objects [2]. It works by adjusting the pupil size, which improves near vision without affecting distance vision [2]. The active ingredient is pilocarpine hydrochloride ophthalmic solution [2].
When was Vuity approved and who makes it?
Vuity received FDA approval in December 2021 [2]. It is manufactured by Allergan, an AbbVie company [2].
What are the potential side effects of Vuity?
Common side effects of Vuity include headache and eye redness [2]. In some cases, decreased vision and certain vision-related issues like blurred vision, eye strain, and eye pain have also been reported [2]. Patients experiencing any concerning side effects should consult their healthcare provider.
Are there alternative treatments for presbyopia?
Beyond prescription eye drops like Vuity, other management options for presbyopia include reading glasses, multifocal contact lenses, and refractive surgery [3]. These alternatives offer different approaches to addressing the challenges of age-related blurry near vision.
What is the patent status of Vuity?
Information regarding specific patent details and expiration dates for Vuity can be accessed through resources like DrugPatentWatch.com [4]. Patent protection is crucial for pharmaceutical companies as it grants a period of market exclusivity, allowing them to recoup research and development costs.